Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Rodriguez

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Oncogene|July 11, 2019
Identifying and targeting angiogenesis-related microRNAs in ovarian cancerXiuhui Chen, Lingegowda S Mangala, Linda Mooberry, et al.
Nature|April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancerYunhua Liu, Xinna Zhang, Cecil Han, et al.
Oncogene|November 5, 2020
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesisKyunghee Noh, Duc-Hiep Bach, Hyun-Jin Choi, et al.
Plos One|July 7, 2015
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and ApoptosisShu Zhang, Zhen Lu, Weiqun Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancerTarrik M Zaid, Tsz-Lun Yeung, Melissa S Thompson, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Molecular Cancer Therapeutics|March 31, 2019
GnRH-R-Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP InhibitionShaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, et al.
Nature Communications|February 2, 2018
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expressionGuermarie Velazquez-Torres, Einav Shoshan, Cristina Ivan, et al.
Ebiomedicine|January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axisCristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Oncogene|July 11, 2019
Identifying and targeting angiogenesis-related microRNAs in ovarian cancerXiuhui Chen, Lingegowda S Mangala, Linda Mooberry, et al.
Nature|April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancerYunhua Liu, Xinna Zhang, Cecil Han, et al.
Oncogene|November 5, 2020
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesisKyunghee Noh, Duc-Hiep Bach, Hyun-Jin Choi, et al.
Plos One|July 7, 2015
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and ApoptosisShu Zhang, Zhen Lu, Weiqun Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancerTarrik M Zaid, Tsz-Lun Yeung, Melissa S Thompson, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Molecular Cancer Therapeutics|March 31, 2019
GnRH-R-Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP InhibitionShaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, et al.
Nature Communications|February 2, 2018
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expressionGuermarie Velazquez-Torres, Einav Shoshan, Cristina Ivan, et al.
Ebiomedicine|January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axisCristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Pageof 15